Filtered By:
Management: Insurance
This page shows you your search results in order of date. This is page number 13.
Order by Relevance | Date
Total 18849 results found since Jan 2013.
Health insurance, labor market shocks, and mental health during the first year of the COVID-19 crisis
Econ Hum Biol. 2023 Aug 23;51:101298. doi: 10.1016/j.ehb.2023.101298. Online ahead of print.ABSTRACTWe use the Census Household Pulse Survey (HPS) to examine employment and earnings loss, health insurance, and hardships related to physical and mental health and health care, as well as food insecurity and difficulty meeting expenses, during the first year of the COVID-19 pandemic. Pandemic job loss is strongly associated with uninsurance in the HPS. Moreover, among those who were not employed due to a pandemic economic reason such as a business closure, we find substantial regression-adjusted differences in hardship by insu...
Source: Economics and Human Biology - September 2, 2023 Category: Biology Authors: Sanders Korenman Rosemary T Hyson Source Type: research
Three-level ACDF versus 3-level laminectomy and fusion: are there differences in outcomes? An analysis of the Quality Outcomes Database cervical spondylotic myelopathy cohort
CONCLUSIONS: In a cohort limited to 3-level fusion surgical procedures, ACDF was associated with reduced blood loss, shorter hospitalization length, and higher routine home discharge rates; however, PCF resulted in lower rates of postoperative dysphagia. The procedures yielded comparably significant improvements in functional status (mJOA score), neck and arm pain, neck pain-related disability, and quality of life at 3, 12, and 24 months. ACDF patients had significantly higher odds of maximum satisfaction (NASS score 1). Given comparable outcomes, patients should be counseled on each approach's complication profile to aid ...
Source: Neurosurgical Focus - September 1, 2023 Category: Neurosurgery Authors: Vardhaan S Ambati Mohamed Macki Andrew K Chan Giorgos D Michalopoulos Vivian P Le Alysha B Jamieson Dean Chou Christopher I Shaffrey Oren N Gottfried Erica F Bisson Anthony L Asher Domagoj Coric Eric A Potts Kevin T Foley Michael Y Wang Kai-Ming Fu Michae Source Type: research
Factors affecting retirement and workforce attrition in neurosurgery: results of a Council of State Neurosurgical Societies national survey
CONCLUSIONS: This study demonstrates that midcareer neurosurgeons may benefit from targeted retention efforts. This effort should focus on maximizing professional satisfaction and financial independence, while decreasing the regulatory burden associated with certification and insurance authorization. End-of-career surgeons should be surveyed to determine factors contributing to resilience and persistence within the neurosurgical workforce.PMID:37657112 | DOI:10.3171/2023.7.JNS231117
Source: Journal of Neurosurgery - September 1, 2023 Category: Neurosurgery Authors: Akshay M Sharma Steven Tenny George L Yang Joseph Cheng John K Ratliff Michael P Steinmetz Satish Krishnamurthy Owoicho Adogwa Karin Swartz Source Type: research
Cost-effectiveness of combination therapy of polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin, and prednisolone for previously untreated diffuse large B-cell lymphoma in Japan
CONCLUSIONS: This study suggests that Pola + R-CHP is a cost-effective treatment for previously untreated DLBCL in Japan under the public health insurance system.PMID:37656225 | DOI:10.1080/13696998.2023.2254162
Source: Journal of Medical Economics - September 1, 2023 Category: Health Management Authors: Takashi Mizuoka Hiroyuki Sakamaki Shigeo Fuji Shota Saito Tatsunori Murata Shinya Ohno Naoki Inubashiri Tomoha Oshima Kazuhito Yamamoto Source Type: research
Economic burden of cancer attributable to modifiable risk factors in Japan
This study aimed to estimate the economic burden of cancer attributable to major lifestyle and environmental risk factors in Japan in 2015. We evaluated the economic cost of cancer attributable to modifiable risk factors from a societal perspective. We obtained the direct medical costs for 2015 from the National Database of Health Insurance Claims and Specific Health Checkups of Japan, and estimated the indirect costs of premature mortality and of morbidity due to cancer using the relevant national surveys in Japan. Finally, we estimated the economic cost of cancer associated with lifestyle and environmental risk factors. ...
Source: Cancer Control - September 1, 2023 Category: Cancer & Oncology Authors: Eiko Saito Shiori Tanaka Sarah Krull Abe Mayo Hirayabashi Junko Ishihara Kota Katanoda Yingsong Lin Chisato Nagata Norie Sawada Ribeka Takachi Atsushi Goto Junko Tanaka Kayo Ueda Megumi Hori Tomohiro Matsuda Manami Inoue Source Type: research
Three-level ACDF versus 3-level laminectomy and fusion: are there differences in outcomes? An analysis of the Quality Outcomes Database cervical spondylotic myelopathy cohort
CONCLUSIONS: In a cohort limited to 3-level fusion surgical procedures, ACDF was associated with reduced blood loss, shorter hospitalization length, and higher routine home discharge rates; however, PCF resulted in lower rates of postoperative dysphagia. The procedures yielded comparably significant improvements in functional status (mJOA score), neck and arm pain, neck pain-related disability, and quality of life at 3, 12, and 24 months. ACDF patients had significantly higher odds of maximum satisfaction (NASS score 1). Given comparable outcomes, patients should be counseled on each approach's complication profile to aid ...
Source: Neurosurgical Focus - September 1, 2023 Category: Neurosurgery Authors: Vardhaan S Ambati Mohamed Macki Andrew K Chan Giorgos D Michalopoulos Vivian P Le Alysha B Jamieson Dean Chou Christopher I Shaffrey Oren N Gottfried Erica F Bisson Anthony L Asher Domagoj Coric Eric A Potts Kevin T Foley Michael Y Wang Kai-Ming Fu Michae Source Type: research
Cost-effectiveness of combination therapy of polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin, and prednisolone for previously untreated diffuse large B-cell lymphoma in Japan
CONCLUSIONS: This study suggests that Pola + R-CHP is a cost-effective treatment for previously untreated DLBCL in Japan under the public health insurance system.PMID:37656225 | DOI:10.1080/13696998.2023.2254162
Source: Journal of Medical Economics - September 1, 2023 Category: Health Management Authors: Takashi Mizuoka Hiroyuki Sakamaki Shigeo Fuji Shota Saito Tatsunori Murata Shinya Ohno Naoki Inubashiri Tomoha Oshima Kazuhito Yamamoto Source Type: research
Determinants of Cervical Cancer Screening Among Women Aged 30-49 Years Old in Four African Countries: A Cross-Sectional Secondary Data Analysis
CONCLUSION: The prevalence of cervical cancer screening in Kenya, Cameroon, Nambia, and Zimbabwe was low as compared to World Health Organization (WHO) recommendations. Age, residence, work status, smoking status, women's age at first birth, condom use, husbands having work, wealth status, and health insurance were the identified determinants of cervical cancer screening. Programme and policy interventions could address younger, rural residence women, poor wealth status women, women without work, and those who never use health insurance for the uptake of cervical cancer screening.PMID:37656980 | DOI:10.1177/10732748231195681
Source: Cancer Control - September 1, 2023 Category: Cancer & Oncology Authors: Melsew Setegn Alie Yilkal Negesse Mengistu Ayenew Source Type: research
Healthcare costs and resource utilization in patients with migraine treated with erenumab: A retrospective, non-interventional study using claims data from the United States
CONCLUSION: Initiation of therapy with a novel treatment is often associated with an increase in overall healthcare costs due to the entrance costs associated with novel therapy. For a chronic condition such as migraine, cost versus health benefits should be evaluated over a long period (e.g., ≥2 years) to better understand the true benefits of therapy. Data from this study suggest that the entrance cost for erenumab, the primary driver of the high post-index prescription costs gets mitigated by reduced medical costs over long-term follow-up. The results indicate better disease management in adult patients with migraine,...
Source: Headache - September 1, 2023 Category: Neurology Authors: Stewart J Tepper Todd J Schwedt Pamela Vo Jeffrey Thompson Parth Joshi Ahmad Abdrabboh Matias Ferraris Santosh Tiwari Source Type: research
Cost-effectiveness of combination therapy of polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin, and prednisolone for previously untreated diffuse large B-cell lymphoma in Japan
CONCLUSIONS: This study suggests that Pola + R-CHP is a cost-effective treatment for previously untreated DLBCL in Japan under the public health insurance system.PMID:37656225 | DOI:10.1080/13696998.2023.2254162
Source: Journal of Medical Economics - September 1, 2023 Category: Health Management Authors: Takashi Mizuoka Hiroyuki Sakamaki Shigeo Fuji Shota Saito Tatsunori Murata Shinya Ohno Naoki Inubashiri Tomoha Oshima Kazuhito Yamamoto Source Type: research
Three-level ACDF versus 3-level laminectomy and fusion: are there differences in outcomes? An analysis of the Quality Outcomes Database cervical spondylotic myelopathy cohort
CONCLUSIONS: In a cohort limited to 3-level fusion surgical procedures, ACDF was associated with reduced blood loss, shorter hospitalization length, and higher routine home discharge rates; however, PCF resulted in lower rates of postoperative dysphagia. The procedures yielded comparably significant improvements in functional status (mJOA score), neck and arm pain, neck pain-related disability, and quality of life at 3, 12, and 24 months. ACDF patients had significantly higher odds of maximum satisfaction (NASS score 1). Given comparable outcomes, patients should be counseled on each approach's complication profile to aid ...
Source: Neurosurgical Focus - September 1, 2023 Category: Neurosurgery Authors: Vardhaan S Ambati Mohamed Macki Andrew K Chan Giorgos D Michalopoulos Vivian P Le Alysha B Jamieson Dean Chou Christopher I Shaffrey Oren N Gottfried Erica F Bisson Anthony L Asher Domagoj Coric Eric A Potts Kevin T Foley Michael Y Wang Kai-Ming Fu Michae Source Type: research
Factors affecting retirement and workforce attrition in neurosurgery: results of a Council of State Neurosurgical Societies national survey
CONCLUSIONS: This study demonstrates that midcareer neurosurgeons may benefit from targeted retention efforts. This effort should focus on maximizing professional satisfaction and financial independence, while decreasing the regulatory burden associated with certification and insurance authorization. End-of-career surgeons should be surveyed to determine factors contributing to resilience and persistence within the neurosurgical workforce.PMID:37657112 | DOI:10.3171/2023.7.JNS231117
Source: Journal of Neurosurgery - September 1, 2023 Category: Neurosurgery Authors: Akshay M Sharma Steven Tenny George L Yang Joseph Cheng John K Ratliff Michael P Steinmetz Satish Krishnamurthy Owoicho Adogwa Karin Swartz Source Type: research
Healthcare costs and resource utilization in patients with migraine treated with erenumab: A retrospective, non-interventional study using claims data from the United States
CONCLUSION: Initiation of therapy with a novel treatment is often associated with an increase in overall healthcare costs due to the entrance costs associated with novel therapy. For a chronic condition such as migraine, cost versus health benefits should be evaluated over a long period (e.g., ≥2 years) to better understand the true benefits of therapy. Data from this study suggest that the entrance cost for erenumab, the primary driver of the high post-index prescription costs gets mitigated by reduced medical costs over long-term follow-up. The results indicate better disease management in adult patients with migraine,...
Source: Headache - September 1, 2023 Category: Neurology Authors: Stewart J Tepper Todd J Schwedt Pamela Vo Jeffrey Thompson Parth Joshi Ahmad Abdrabboh Matias Ferraris Santosh Tiwari Source Type: research
